text
"['\n2. 연결재무제표\n가. 연결재무상태표\n반 기 연 결 재 무 상 태 표\n\xa0제 74 기 \xa0반기 : \xa02022년 06월 30일 현재\n\xa0제 73 기 \xa0 \xa0 \xa0 \xa0 \xa0 : \xa02021년 12월 31일 현재\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0목\n주 \xa0석\n제 74(당) 반기\n제 73(전)기\n자 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0산\nI. 현금및현금성자산\n5,6,7\n1,456,011,146,904\n1,336,123,701,794\nII. 예치금\n5,6,7\n1,395,509,270,559\n1,263,131,548,482\nIII. 당기손익인식유가증권\n5,6,8\n15,905,963,654,887\n15,393,214,070,128\nIV. 매도가능유가증권\n5,6,8\n41,285,842,212,839\n75,750,100,062,099\nV. 만기보유유가증권\n5,6,8\n31,554,147,654,536\n-\nVI. 관계기업 및 공동기업투자\n10\n350,550,522,706\n367,916,057,187\nVII. 대출채권\n5,6,11\n31,397,139,225,846\n31,406,446,048,053\nVIII. 유형자산\n13,14\n1,793,171,144,781\n1,884,292,428,228\nIX. 투자부동산\n13,14\n2,449,403,189,263\n2,497,974,077,428\nX. 무형자산\n14\n1,128,362,528,900\n1,161,794,729,364\nXI. 사용권자산\n14,15\n170,363,250,852\n124,833,212,785\nXII. 파생상품자산\n5,6,12\n296,784,615,074\n181,065,508,607\nXIII.순확정급여자산\n23\n16,582,735,763\n25,369,066,995\nXIV. 당기법인세자산\n64,668,474,308\n16,887,406,268\nXV. 이연법인세자산\n1,423,708,247,925\n138,927,518,553\nXVI. 기타금융자산\n5,6,16\n2,601,907,127,378\n2,571,857,011,253\nXVII. 기타자산\n17\n3,506,260,281,261\n3,289,958,225,995\nXVIII. 특별계정자산\n22\n23,814,164,633,768\n26,181,482,454,112\n자 \xa0 \xa0 \xa0산 \xa0 \xa0 \xa0총 \xa0 \xa0 \xa0계\n160,610,539,917,550\n163,591,373,127,331\n부 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0채\nI. 보험계약부채\n18\n109,813,281,765,274\n108,406,647,948,707\nII. 계약자지분조정\n19\n(540,254,450)\n348,385,730,949\nIII. 당기손익인식금융부채\n5,6,20\n1,902,109,562,533\n1,356,665,829,342\nIV. 차입부채 및 사채\n5,6,21\n8,572,785,512,198\n6,987,337,243,747\nV. 당기법인세부채\n55,578,028,290\n65,400,735,575\nVI. 이연법인세부채\n529,241,273,139\n585,246,346,252\nVII. 파생상품부채\n5,6,12\n2,819,356,696,782\n989,410,715,345\nVIII. 순확정급여부채\n23\n281,805,619,775\n287,991,084,152\nIX. 충당부채\n24\n93,388,371,930\n89,667,427,257\nX. 기타금융부채\n5,6,15,25\n3,651,029,084,097\n4,075,086,831,812\nXI. 기타부채\n26\n222,110,300,260\n233,646,430,078\nXII. 특별계정부채\n22\n23,793,059,050,920\n26,746,305,789,455\n부 \xa0 \xa0 \xa0채 \xa0 \xa0 \xa0총 \xa0 \xa0 \xa0계\n151,733,205,010,748\n150,171,792,112,671\n자 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0본\n지배기업의 소유주에게 귀속되는 자본\nI. 자본금\n27\n4,342,650,000,000\n4,342,650,000,000\nII. 기타불입자본\n27\n(447,887,377,127)\n(452,754,777,309)\nIII. 신종자본증권\n28\n1,558,370,079,138\n2,056,343,999,076\nIV. 기타자본구성요소\n29\n(3,443,878,229,042)\n244,554,628,930\nV. 이익잉여금\n30\n5,379,084,759,830\n5,083,054,481,257\n비지배지분\n1,488,995,674,003\n2,145,732,682,706\n자 \xa0 \xa0 \xa0 본 \xa0 \xa0 \xa0 총 \xa0 \xa0 \xa0 계\n8,877,334,906,802\n13,419,581,014,660\n부 \xa0채 \xa0및 \xa0자 \xa0본 \xa0총 \xa0계\n160,610,539,917,550\n163,591,373,127,331\n나. 연결포괄손익계산서\n\xa0반 기 연 결 포 괄 손 익 계 산 서\n제 74 기 반기 : 2022년 1월 1일부터 2022년 06월 30일까지\n제 73 기 반기 : 2021년 1월 1일부터 2021년 06월 30일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0목\n주 석\n제 74(당) 반기\n제 73(전) 반기\n3 개 월\n\xa0누 \xa0 적\n3 개 월\n누 \xa0 적\nI. 영업수익\n8,171,374,988,223\n15,426,949,894,645\n5,898,254,495,283\n12,905,840,181,797\n\xa0 1. 보험료수익\n32\n4,269,845,708,844\n8,388,964,832,576\n3,888,748,731,377\n7,878,796,964,897\n\xa0 2. 재보험수익\n33\n364,139,948,954\n716,141,313,493\n328,952,169,282\n649,426,252,154\n\xa0 3. 이자수익\n31,42\n823,258,665,983\n1,633,782,342,661\n731,182,133,095\n1,443,119,610,897\n\xa0 4. 당기손익인식유가증권 평가 및 처분이익\n31\n277,034,069,705\n481,490,107,663\n134,964,323,324\n225,644,888,944\n\xa0 5. 매도가능유가증권 평가 및 처분이익\n31\n191,751,910,209\n324,887,663,743\n188,174,492,915\n437,752,175,549\n\xa0 6. 외환거래이익\n31\n1,205,762,802,722\n1,715,987,781,986\n23,373,153,848\n980,730,221,416\n\xa0 7. 파생상품평가 및 거래이익\n12,31\n459,072,248,224\n863,245,788,784\n47,589,716,403\n193,046,468,856\n\xa0 8. 기타수익\n34\n303,915,332,125\n755,907,792,771\n288,340,869,291\n509,228,636,129\n\xa0 9. 특별계정수입수수료\n213,590,162,726\n429,710,532,995\n227,854,820,043\n500,237,188,780\n\xa0 10. 특별계정수익\n22\n63,004,138,731\n116,831,737,973\n39,074,085,705\n87,857,774,175\nII. 영업비용\n7,713,366,081,750\n14,838,204,261,988\n5,657,478,202,001\n12,228,362,049,667\n\xa0 1. 보험계약부채전입액\n18\n961,948,444,448\n1,354,030,468,460\n919,123,913,684\n1,642,245,066,266\n\xa0 2. 지급보험금\n35,42\n3,239,601,608,801\n6,968,302,788,456\n3,064,606,079,596\n6,429,245,703,422\n\xa0 3. 재보험비용\n33\n417,221,223,310\n808,481,946,745\n374,217,184,907\n736,458,301,142\n\xa0 4. 사업비\n36,42\n469,649,536,572\n910,224,911,148\n592,305,524,179\n1,085,854,613,972\n\xa0 5. 신계약비상각비\n17\n314,185,496,566\n598,921,755,527\n302,723,340,618\n620,497,604,958\n\xa0 6. 재산관리비\n37,42\n58,505,416,826\n107,012,296,218\n51,822,491,339\n75,148,026,364\n\xa0 7. 손해조사비\n38\n35,896,597,120\n69,251,322,320\n30,070,700,586\n59,048,436,560\n\xa0 8. 구상손실\n607,193,482\n1,702,988,953\n338,279,001\n1,246,870,590\n\xa0 9. 당기손익인식유가증권 평가 및 처분손실\n31\n246,089,110,010\n566,100,944,554\n11,108,342,032\n47,817,794,260\n\xa0 10. 매도가능유가증권 평가 및 처분손실\n31\n95,638,525,639\n137,513,056,969\n17,020,720,303\n28,717,555,175\n\xa0 11. 대출채권및수취채권 평가 및 처분손실\n31\n(4,757,442,229)\n6,661,222,676\n3,840,595,451\n11,880,381,889\n\xa0 12. 외환거래손실\n31\n134,485,646,673\n263,961,050,743\n754,187,088\n48,215,047,595\n\xa0 13. 파생상품평가 및 거래손실\n12,31\n1,455,417,883,827\n2,402,323,082,206\n102,377,030,881\n1,098,291,150,293\n\xa0 14. 기타비용\n39\n202,731,438,589\n483,849,027,132\n141,401,025,933\n239,274,198,191\n\xa0 15. 특별계정지급수수료\n23,141,263,385\n43,035,661,908\n6,694,700,698\n16,563,524,815\n\xa0 16. 특별계정비용\n22\n63,004,138,731\n116,831,737,973\n39,074,085,705\n87,857,774,175\nIII. 영업이익\n458,008,906,473\n588,745,632,657\n240,776,293,282\n677,478,132,130\nIV. 영업외수익\n40\n11,292,079,812\n53,294,233,083\n7,046,292,168\n26,111,358,040\nV. 영업외비용\n40\n21,497,014,537\n57,099,565,226\n7,883,359,694\n14,203,636,446\nVI. 법인세비용차감전순이익\n447,803,971,748\n584,940,300,514\n239,939,225,756\n689,385,853,724\nVII. 법인세비용\n41\n129,200,145,695\n167,530,942,368\n74,677,945,163\n187,733,244,548\nVIII. 반기순이익\n318,603,826,053\n417,409,358,146\n165,261,280,593\n501,652,609,176\nIX. 법인세비용차감후 기타포괄손익\n(2,500,791,253,333)\n(4,398,452,172,174)\n21,442,008,298\n(1,871,101,980,501)\n\xa0 1. 당기손익으로 재분류되지 않는 포괄손익\n(3,684,047,159)\n(4,830,161,230)\n2,537,794,988\n14,081,736,579\n\xa0 \xa01) 유형자산재평가이익\n(3,684,047,159)\n(670,860,885)\n2,617,017,882\n4,551,803,814\n\xa0 \xa02) 순확정급여부채의 재측정요소\n-\n(4,159,300,345)\n(79,222,894)\n9,529,932,765\n\xa0 2. 후속적으로 당기손익으로 재분류될 수  \xa0 \xa0 \xa0있는 포괄손익\n(2,497,107,206,174)\n(4,393,622,010,944)\n18,904,213,310\n(1,885,183,717,080)\n\xa0 \xa01) 매도가능금융자산평가손익\n(2,132,307,114,817)\n(3,513,770,021,561)\n56,818,823,858\n(1,767,486,778,459)\n\xa0 \xa02) 만기보유금융자산평가손익\n7,831,472,952\n(117,736,221,822)\n-\n-\n\xa0 \xa03) 관계기업의 기타포괄손익지분\n(11,576,253)\n(17,213,112,054)\n3,274,988,204\n3,141,726,263\n\xa0 \xa04) 위험회피목적파생상품평가손익\n(283,634,791,198)\n(563,005,619,155)\n(16,316,581,658)\n(76,523,084,537)\n\xa0 \xa05) 특별계정기타포괄손익\n(119,623,948,713)\n(226,184,347,098)\n(24,100,736,877)\n(60,098,230,478)\n\xa0 \xa06) 해외사업장환산외환차이\n30,638,751,855\n44,287,310,746\n(772,280,217)\n15,782,650,131\nX. 반기총포괄손익\n(2,182,187,427,280)\n(3,981,042,814,028)\n186,703,288,891\n(1,369,449,371,325)\nXI. 반기순손익의 귀속\n318,603,826,053\n417,409,358,146\n165,261,280,593\n501,652,609,176\n\xa0 1. 지배기업의 소유주\n291,721,927,182\n331,370,906,062\n159,962,525,982\n471,434,836,910\n\xa0 2. 비지배지분\n26,881,898,871\n86,038,452,084\n5,298,754,611\n30,217,772,266\nXII. 반기총포괄손익의 귀속\n(2,182,187,427,280)\n(3,981,042,814,028)\n186,703,288,891\n(1,369,449,371,325)\n\xa0 1. 지배기업의 소유주\n(1,811,807,354,843)\n(3,346,845,654,555)\n177,527,572,153\n(1,239,756,049,921)\n\xa0 2. 비지배지분\n(370,380,072,437)\n(634,197,159,473)\n9,175,716,738\n(129,693,321,404)\nXIII. 주당이익\n\xa0 1. 기본주당이익\xa0\n359\n379\n182\n564\n\xa0 2. 희석주당이익\n359\n379\n181\n563\n다. 연결자본변동표\n반 기 연 결 자 본 변 동 표\n제 74 기 반기 : 2022년 1월 1일부터 2022년 06월 30일까지\n제 73 기 반기 : 2021년 1월 1일부터 2021년 06월 30일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 목\n자 \xa0본 \xa0금\n기타불입자본\n신종자본증권\n기타자본구성요소\n이익잉여금\n지배기업의소유주 귀속\n비지배지분\n총 \xa0 \xa0계\n2021.1.1 (전기초)\n4,342,650,000,000\n(454,116,554,271)\n2,056,343,999,076\n2,680,981,572,966\n3,251,081,150,050\n11,876,940,167,821\n1,277,694,207,424\n13,154,634,375,245\nI. 반기총포괄손익\n\xa01. 반기순이익\n-\n-\n-\n-\n471,434,836,910\n471,434,836,910\n30,217,772,266\n501,652,609,176\n\xa02. 재평가잉여금의대체\n-\n-\n-\n(3,726,157,900)\n3,726,157,900\n-\n-\n-\n\xa03. 유형자산재평가이익\n-\n-\n-\n4,551,803,814\n-\n4,551,803,814\n-\n4,551,803,814\n\xa04. 확정급여제도의 재측정요소\n-\n-\n-\n9,529,932,765\n-\n9,529,932,765\n-\n9,529,932,765\n\xa05. 매도가능금융자산평가손익\n-\n-\n-\n(1,611,918,034,251)\n-\n(1,611,918,034,251)\n(155,568,744,208)\n(1,767,486,778,459)\n\xa06. 관계기업의 기타포괄손익지분\n-\n-\n-\n2,712,950,300\n-\n2,712,950,300\n428,775,963\n3,141,726,263\n\xa07. 위험회피목적파생상품평가손익\n-\n-\n-\n(71,761,143,567)\n-\n(71,761,143,567)\n(4,761,940,970)\n(76,523,084,537)\n\xa08. 특별계정기타포괄손익\n-\n-\n-\n(60,084,236,313)\n-\n(60,084,236,313)\n(13,994,165)\n(60,098,230,478)\n\xa09. 해외사업환산손익\n-\n-\n-\n15,777,840,421\n-\n15,777,840,421\n4,809,710\n15,782,650,131\nII. 자본에 직접 인식된 주주와의 거래\n\xa01. 연차배당\n-\n-\n-\n-\n(22,541,707,500)\n(22,541,707,500)\n-\n(22,541,707,500)\n\xa02. 신종자본증권 배당\n-\n-\n-\n-\n(46,957,324,634)\n(46,957,324,634)\n(6,160,000,000)\n(53,117,324,634)\n\xa03. 주식기준보상\n-\n1,517,310,900\n-\n-\n-\n1,517,310,900\n507,132,920\n2,024,443,820\nⅢ. 비지배지분의 증감\n-\n(1,198,661,864)\n-\n2,662,276\n-\n(1,195,999,588)\n37,629,039,446\n36,433,039,858\n2021.6.30 (전반기말)\n4,342,650,000,000\n(453,797,905,235)\n2,056,343,999,076\n966,067,190,511\n3,656,743,112,726\n10,568,006,397,078\n1,179,977,058,386\n11,747,983,455,464\n2022.1.1 (당기초)\n4,342,650,000,000\n(452,754,777,309)\n2,056,343,999,076\n244,554,628,930\n5,083,054,481,257\n11,273,848,331,954\n2,145,732,682,706\n13,419,581,014,660\nI. 반기총포괄손익\n\xa01. 반기순이익\n-\n-\n-\n-\n331,370,906,062\n331,370,906,062\n86,038,452,084\n417,409,358,146\n\xa02. 재평가잉여금의대체\n-\n-\n-\n(10,216,297,355)\n10,216,297,355\n-\n-\n-\n\xa03. 유형자산재평가이익\n-\n-\n-\n(670,860,885)\n\u3000\n(670,860,885)\n-\n(670,860,885)\n\xa04. 확정급여제도의 재측정요소\n-\n-\n-\n(4,159,300,345)\n-\n(4,159,300,345)\n-\n(4,159,300,345)\n\xa05. 매도가능금융자산평가손익\n-\n-\n-\n(2,859,373,353,034)\n-\n(2,859,373,353,034)\n(654,396,668,527)\n(3,513,770,021,561)\n\xa06. 만기보유금융자산평가손익\n-\n-\n-\n(117,736,221,822)\n-\n(117,736,221,822)\n-\n(117,736,221,822)\n\xa07. 관계기업의 기타포괄손익지분\n-\n-\n-\n(8,099,679,481)\n\u3000\n(8,099,679,481)\n(9,113,432,573)\n(17,213,112,054)\n\xa08. 위험회피목적파생상품평가손익\n-\n-\n-\n(503,115,732,569)\n-\n(503,115,732,569)\n(59,889,886,586)\n(563,005,619,155)\n\xa09. 특별계정기타포괄손익\n-\n-\n-\n(226,206,675,020)\n-\n(226,206,675,020)\n22,327,922\n(226,184,347,098)\n\xa010. 해외사업환산손익\n-\n-\n-\n41,145,262,539\n-\n41,145,262,539\n3,142,048,207\n44,287,310,746\nII. 자본에 직접 인식된 주주와의 거래\n\xa01. 연차배당\n-\n-\n-\n-\n-\n-\n(24,050,643,200)\n(24,050,643,200)\n\xa02. 신종자본증권 발행\n-\n-\n-\n-\n-\n-\n35,000,000,000\n35,000,000,000\n\xa03. 신종자본증권 상환\n-\n(2,026,080,062)\n(497,973,919,938)\n-\n-\n(500,000,000,000)\n(30,000,000,000)\n(530,000,000,000)\n\xa04. 신종자본증권 배당\n-\n-\n-\n-\n(45,556,924,844)\n(45,556,924,844)\n(6,477,500,000)\n(52,034,424,844)\n\xa05. 주식기준보상\n-\n3,558,017,150\n-\n-\n-\n3,558,017,150\n1,427,526,717\n4,985,543,867\nIII. 비지배지분의 증감\n-\n3,335,463,094\n-\n-\n-\n3,335,463,094\n1,560,767,253\n4,896,230,347\n2022.6.30 (당반기말)\n4,342,650,000,000\n(447,887,377,127)\n1,558,370,079,138\n(3,443,878,229,042)\n5,379,084,759,830\n7,388,339,232,799\n1,488,995,674,003\n8,877,334,906,802\n라. 연결현금흐름표\n반 기 연 결 현 금 흐 름 표\n제 74 기 반기 : 2022년 1월 1일부터 2022년 06월 30일까지\n제 73 기 반기 : 2021년 1월 1일부터 2021년 06월 30일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0목\n주 석\n제 74(당) 반기\n제 73(전) 반기\nⅠ. 영업활동으로 인한 현금흐름\n\u3000\n330,112,481,772\n2,211,829,904,695\n\xa0 \xa0 1. 반기순이익\n417,409,358,146\n\u3000\n501,652,609,176\n\xa0 \xa0 2. 조정\n44\n371,047,508,854\n\u3000\n452,970,567,864\n\xa0 \xa0 3. 영업활동으로 인한 자산ㆍ부채의 변동\n44\n(2,143,096,450,172)\n\u3000\n(484,491,661,131)\n\xa0 \xa0 4. 이자의 수취\n1,506,680,511,204\n\u3000\n1,410,796,515,998\n\xa0 \xa0 5. 이자의 지급\n(75,632,114,622)\n\u3000\n(15,248,135,863)\n\xa0 \xa0 6. 배당금의 수취\n432,462,491,955\n\u3000\n289,288,905,756\n\xa0 \xa0 7. 법인세부담액\n(178,758,823,593)\n\u3000\n56,861,102,896\nⅡ. 투자활동으로 인한 현금흐름\n\u3000\n(1,188,170,660,348)\n(2,317,232,690,388)\n\xa0 \xa0 1. 매도가능금융자산의 처분\n5,679,389,812,236\n\u3000\n5,123,736,793,115\n\xa0 \xa0 2. 만기보유금융자산의 상환\n10,597,139,798\n\u3000\n-\n\xa0 \xa0 3. 투자부동산 및 유형자산의 처분\n146,770,020,309\n\u3000\n20,306,864,716\n\xa0 \xa0 4. 무형자산의 처분\n5,943,348,671\n\u3000\n2,081,333,600\n\xa0 \xa0 5. 관계기업투자의 처분\n22,011,145,824\n\u3000\n10,450,000,000\n\xa0 \xa0 6. 관계기업투자의 배당\n3,988,050,432\n\u3000\n3,518,424,406\n\xa0 \xa0 7. 예치보증금의 감소\n13,308,201,647\n\u3000\n10,403,009,567\n\xa0 \xa0 8. 기타금융부채의 증가\n-\n310,500,000\n\xa0 \xa0 9. 금융리스채권의 감소\n316,537,254\n\u3000\n-\n\xa0 \xa0 10. 위험회피목적 파생상품의 정산\n(285,506,840,886)\n\u3000\n73,058,202,640\n\xa0 \xa0 11. 매도가능금융자산의 취득\n(3,805,304,677,488)\n\u3000\n(7,434,236,562,298)\n\xa0 \xa0 12. 만기보유금융자산의 취득\n(2,824,922,331,015)\n\u3000\n-\n\xa0 \xa0 13. 투자부동산 및 유형자산의 취득\n(38,386,970,024)\n\u3000\n(39,099,202,513)\n\xa0 \xa0 14. 관계기업투자의 취득\n(60,566,773,598)\n\u3000\n(19,363,980,912)\n\xa0 \xa0 15. 무형자산의 취득\n(18,150,617,230)\n\u3000\n(57,192,366,741)\n\xa0 \xa0 16. 예치보증금의 증가\n(29,046,860,243)\n\u3000\n(6,082,599,071)\n\xa0 \xa0 17. 선급금의 증가\n(8,609,846,035)\n\u3000\n(5,123,106,897)\nⅢ. 재무활동으로 인한 현금흐름\n\u3000\n965,472,185,469\n(34,951,896,022)\n\xa0 \xa0 1. 비지배지분의 증가\n35,745,000,000\n\u3000\n36,941,117,260\n\xa0 \xa0 2. 비지배지분의 감소\n(60,528,143,200)\n\u3000\n(6,673,401,950)\n\xa0 \xa0 3. 임대보증금 증가\n17,390,847,267\n\u3000\n4,501,926,967\n\xa0 \xa0 4. 임대보증금 감소\n(15,118,637,147)\n\u3000\n(7,449,776,524)\n\xa0 \xa0 5. 신종자본증권 배당\n(49,798,167,123)\n(42,326,400,000)\n\xa0 \xa0 6. 신종자본증권의 상환\n(500,000,000,000)\n-\n\xa0 \xa0 7. 배당금의 지급\n-\n\u3000\n(22,541,707,500)\n\xa0 \xa0 8. 차입부채의 감소\n(1,416,737,786,937)\n\u3000\n-\n\xa0 \xa0 9. 차입부채의 증가\n2,886,617,071,076\n\u3000\n-\n\xa0 \xa0 10. 환매조건부채권매도의 순증감\n33,292,715,440\n-\n\xa0 \xa0 11. 기타금융부채의 변동\n65,438,391,039\n32,190,761,189\n\xa0 \xa0 12. 리스부채의 감소\n(30,829,104,946)\n(29,594,415,464)\nⅣ. 현금및현금성자산의 순증가(감소)(Ⅰ+Ⅱ+Ⅲ)\n107,414,006,894\n(140,354,681,715)\nⅤ. 기초 현금및현금성자산\n1,336,123,701,794\n1,051,931,381,296\nⅥ. 외화표시 현금및현금성자산 환율변동효과\n12,473,438,216\n1,822,581,088\nⅦ. 반기말 현금및현금성자산\n1,456,011,146,904\n913,399,280,669\n']"
